Innovating forAffordable Healthcare
Shilpa Medicare is an integrated pharmaceutical company delivering APIs, formulations, complex generics, oncology products and CDMO services to global markets — with a singular mission: to make high-quality healthcare affordable.
Our Core Services
From early development to commercial supply, Shilpa provides fully integrated pharmaceutical solutions — combining deep scientific expertise, robust quality systems and global regulatory experience.
Generic API
High-quality intermediates and APIs manufactured in globally accredited facilities.
- US FDA, EU GMP and other major regulatory approvals
- Oncology and non-oncology APIs
- Focus on cost-competitiveness and lifecycle optimization
Generic Formulations
Development and commercial manufacturing of differentiated drug products.
- Oral solids – IR, MR and complex generics
- Oncology and non-oncology injectables
- Specialty dosage forms (OTF, transdermals, sprays)
CDMO Services
End-to-end contract development and manufacturing for small molecules and complex APIs.
- Route scouting to commercial scale-up
- HPAPI / cytotoxic capabilities (OEL 1–5)
- Support across pre-clinical, clinical and commercial phases
Our R&D centers focus on complex generics, oncology APIs, biologics, peptides and advanced delivery systems. By combining deep chemistry, biology and engineering capabilities, we bring difficult-to-make products to market faster — without compromising on quality or patient safety.
35+ Years of Pharmaceutical Excellence
Since 1987, Shilpa Medicare has evolved from a single API facility in Raichur, Karnataka into a diversified pharmaceutical company with integrated strengths across development, manufacturing and commercialization.
Global Reach
Supplying APIs, formulations and oncology products to 50+ markets worldwide.
Quality Assurance
US FDA, EU GMP and other global health authority approvals underpin our quality systems.
R&D Innovation
Four dedicated R&D centers driving innovation in APIs, formulations, biologics and novel delivery platforms.
Accreditations
Our facilities are inspected by leading global health authorities, reflecting our commitment to quality and compliance.
Russian MOH
Ministry of Health of the Russian Federation
US FDA
U.S. Food and Drug Administration
PMDA
Pharmaceuticals and Medical Devices Agency – Japan
EU GMP
Good Manufacturing Practice – European Union
MFDS Korea
Ministry of Food and Drug Safety – South Korea
EDQM
European Directorate for the Quality of Medicines
Canada GMP
Canada's Food and Drugs Act and Regulations
TGA
Therapeutic Goods Administration – Australia
COFEPRIS
Federal Commission for Sanitary Risk – Mexico
ANVISA
National Sanitary Surveillance Agency – Brazil
DIGEMID
General Directorate of Medicines – Peru
Recent Achievements
Milestones that showcase our commitment to pharmaceutical innovation and excellence.
Tranexamic Acid Spray
Received approval for Hemostatic Spray, expanding our specialized product portfolio.
GMP Certification
GMP Certificate issued by UK MHRA for our Dabaspet manufacturing facility.
FKCCI Recognition
Best District Export Excellence Award recognizing our global market contribution.